Resar L, Luo L
Int J Mol Sci. 2025; 26(5).
PMID: 40076747
PMC: 11899949.
DOI: 10.3390/ijms26052125.
Sayed W, Al-Bayati A, Elzubair L, Mohamed S, Alharthi M
Cureus. 2024; 16(11):e74401.
PMID: 39723287
PMC: 11669263.
DOI: 10.7759/cureus.74401.
Saber S, Abdelhady R, Elhemely M, Elmorsy E, Hamad R, Abdel-Reheim M
Front Pharmacol. 2024; 15:1475998.
PMID: 39564119
PMC: 11573589.
DOI: 10.3389/fphar.2024.1475998.
Wang Y, Wei C, Lin C, Gurnari C, Awada H, Benajiba L
Leukemia. 2024; 39(1):144-154.
PMID: 39367172
DOI: 10.1038/s41375-024-02422-4.
Xiong H, Liao M, Zhang H, Li Y, Bai J, Zhang J
Sci Rep. 2024; 14(1):16711.
PMID: 39030308
PMC: 11271514.
DOI: 10.1038/s41598-024-67067-w.
Focal Crescentic Glomerulonephritis Superimposed on Myeloproliferative Disease-Related Glomerulopathy in a Case of Myelofibrosis.
Kunpara J, Darji B, Patel H, Patwari D, Patel S, Darji P
Indian J Nephrol. 2024; 34(1):64-66.
PMID: 38645909
PMC: 11003585.
DOI: 10.4103/ijn.ijn_218_22.
Lysosomal degradation targets mutant calreticulin and the thrombopoietin receptor in myeloproliferative neoplasms.
Kaur A, Venkatesan A, Kandarpa M, Talpaz M, Raghavan M
Blood Adv. 2024; 8(13):3372-3387.
PMID: 38640435
PMC: 11255115.
DOI: 10.1182/bloodadvances.2023011432.
Detecting Multiple Driver Mutations in a Patient with Essential Thrombocythemia.
Sharma S, Morisetti M, Gandhi N, Chennapragada S, Cotelingam J, Ramadas P
Am J Case Rep. 2024; 25:e942030.
PMID: 38310350
PMC: 10858393.
DOI: 10.12659/AJCR.942030.
Clonal medicine targeting DNA damage response eradicates leukemia.
Toma M, Karami A, Nieborowska-Skorska M, Chirtala K, Pepek M, Hadzijusufovic E
Leukemia. 2024; 38(3):671-675.
PMID: 38228681
PMC: 10912018.
DOI: 10.1038/s41375-024-02138-5.
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms.
Gou P, Liu D, Ganesan S, Lauret E, Maslah N, Parietti V
Blood Cancer J. 2024; 14(1):1.
PMID: 38177095
PMC: 10766605.
DOI: 10.1038/s41408-023-00969-6.
Molecular landscape of the gene in chronic myeloproliferative neoplasm patients from the state of Amazonas, Brazil.
Torres D, Barbosa Alves E, Araujo de Sousa M, Laranjeira W, Paes J, Alves E
Biomed Rep. 2023; 19(6):98.
PMID: 37954635
PMC: 10633817.
DOI: 10.3892/br.2023.1680.
Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow.
Holmstrom M, Andersen M, Traynor S, Ahmad S, Landkildehus Lisle T, Grauslund J
Front Immunol. 2023; 14:1240678.
PMID: 37662956
PMC: 10470021.
DOI: 10.3389/fimmu.2023.1240678.
Myeloproliferative neoplasms - blurring the lines between cancer and chronic inflammatory disorder.
Soyfer E, Fleischman A
Front Oncol. 2023; 13:1208089.
PMID: 37361587
PMC: 10288874.
DOI: 10.3389/fonc.2023.1208089.
Cerebral Sinus Vein Thrombosis and Gender: A Not Entirely Casual Relationship.
Ciarambino T, Crispino P, Minervini G, Giordano M
Biomedicines. 2023; 11(5).
PMID: 37238951
PMC: 10216036.
DOI: 10.3390/biomedicines11051280.
Primary myelofibrosis-related glomerulopathy with renal extramedullary hematopoiesis.
Kim H, Jung M, Lim B, Cheong J, Han S
J Nephrol. 2023; 36(8):2387-2390.
PMID: 37067698
DOI: 10.1007/s40620-023-01621-z.
Epigenetic regulation by ASXL1 in myeloid malignancies.
Yang F, Agosto-Pena J
Int J Hematol. 2023; 117(6):791-806.
PMID: 37062051
DOI: 10.1007/s12185-023-03586-y.
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.
Ivanov D, Milosevic Feenstra J, Sadovnik I, Herrmann H, Peter B, Willmann M
Am J Hematol. 2023; 98(5):770-783.
PMID: 36814396
PMC: 10952374.
DOI: 10.1002/ajh.26889.
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities.
Fosselteder J, Pabst G, Sconocchia T, Schlacher A, Auinger L, Kashofer K
Leukemia. 2023; 37(4):843-853.
PMID: 36813992
PMC: 10079532.
DOI: 10.1038/s41375-023-01848-6.
Clonal evolution analysis of a rare acute promyelocytic leukemia patient transforming from essential thrombocythemia.
Zhang R, Liu Y, Song H, Tan Y, Jin W, Zhao H
Ann Hematol. 2023; 102(4):981-984.
PMID: 36749404
DOI: 10.1007/s00277-023-05112-w.
Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology.
Chia Y, Siti Asmaa M, Ramli M, Woon P, Johan M, Hassan R
Diagnostics (Basel). 2023; 13(1).
PMID: 36611455
PMC: 9818412.
DOI: 10.3390/diagnostics13010163.
